Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Ferring Pharmaceuticals is recalling 72,046 cartons of Endometrin vaginal inserts nationwide due to discoloration caused by heat exposure.
FDA is recalling HCG 125U/Tab Tablet Tritu compounded by MD Custom Rx due to the use of an incorrect solvent.
MD Custom Rx is recalling HCG and Methylcobalamin drops because they were compounded with an incorrect solvent. The product was distributed in Wisconsin.
MD Custom Rx is recalling HCG drops compounded with an incorrect solvent. The recall is limited to Wisconsin.
Caraco Pharmaceutical Laboratories is recalling specific lots of Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, because stability results showed the product did not meet drug dissolution specifications.
MD Custom Rx is recalling Mometasone irrigation solution compounded with an incorrect solvent. The product was distributed in Wisconsin.
Forest Pharmaceuticals is recalling Bystolic (nebivolol) 20 mg tablets because they failed stage III dissolution testing. The recall affects 92,544 bottles distributed nationwide.
West-Ward Pharmaceutical Corp. is recalling Isoniazid Tablets, USP, 300 mg because stability lots failed to meet dissolution specifications.
MD Custom Rx is recalling Diphenhydramine (Alcohol Base) 25 mg / 0.5 mL Solution because specific products were compounded with an incorrect solvent.
Baxter Healthcare is recalling Brevibloc (esmolol hydrochloride) injection due to complaints of discolored solution and subvisible iron oxide particles.
MD Custom Rx is recalling HCG drops compounded with an incorrect solvent. The recall covers specific lots distributed in Wisconsin.
Caraco Pharmaceutical Laboratories is recalling 200 vials of Gemcitabine For Injection USP due to a lack of assurance of sterility.
Teva Pharmaceuticals is recalling 9,882 bottles of Dextroamphetamine Sulfate 10 mg tablets because stability testing revealed out-of-specification impurities.
Pfizer is recalling Pristiq 50 mg extended-release tablets because a 100 mg tablet was found in a bottle labeled for 50 mg.
Bausch & Lomb is recalling 35,253 tubes of Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, due to crystal precipitate formation causing a gritty sensation in the eye.
Bausch & Lomb is recalling Muro 128 ophthalmic ointment because crystals form in the product, causing a gritty feeling in the eye.
John W Hollis Inc is recalling specific lots of Testosterone Cypionate for Injection because the products lack assurance of sterility.
John W Hollis Inc. is recalling Levocarnitine Solution for injection because the company cannot ensure the product is sterile. The recall covers specific lots distributed nationwide.
John W Hollis Inc is recalling Polidocanol 0.5% Solution for Injection because the products lack assurance of sterility.
John W Hollis Inc is recalling Methylcobalamin 1000 mcg injectable products because they lack assurance of sterility. The recall covers Lot # 1862 distributed nationwide.
John W Hollis Inc is recalling specific lots of Cyanocobalamin injection because the products lack assurance of sterility. The recall covers 2,650 mL distributed nationwide.
John W Hollis Inc is recalling 80 mL vials of Lipotropic Gold injectable products because they may lack sterility assurance.
John W Hollis Inc is recalling B-Complex/Adenosine Injectable Solution due to a lack of sterility assurance in the compounded aseptically filled products.
John W Hollis Inc is recalling MIC Plus B12 injectable vials because the products lack assurance of sterility. Consumers should stop using the affected lots immediately.
John W Hollis Inc is recalling compounded Papaverine HCl and Phentolamine Mesylate injectable products due to a lack of assurance of sterility.